Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial [3]

Genitourinary Medicine

Volumn 72, Issue 1, 1996, Pages 71-

  Gross, G ^a   Rousaki, A ^a   Wiegand, M ^a   Mescheder, A ^a  

^a Hamburg Eppendorf University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON;

CARBON DIOXIDE LASER; CLINICAL TRIAL; COMPLICATION; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG THERAPY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERFERON ALFA-2A; LASER SURGERY; MALE; MIDDLE AGED; RECURRENCE;

EID: 0030059933     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)